Literature DB >> 11418600

The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin.

C Fotinou1, P Emsley, I Black, H Ando, H Ishida, M Kiso, K A Sinha, N F Fairweather, N W Isaacs.   

Abstract

Tetanus toxin, a member of the family of Clostridial neurotoxins, is one of the most potent toxins known. The crystal structure of the complex of the COOH-terminal fragment of the heavy chain with an analogue of its ganglioside receptor, GT1b, provides the first direct identification and characterization of the ganglioside-binding sites. The ganglioside induces cross-linking by binding to two distinct sites on the Hc molecule. The structure sheds new light on the binding of Clostridial neurotoxins to receptors on neuronal cells and provides important information relevant to the design of anti-tetanus and anti-botulism therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418600     DOI: 10.1074/jbc.M103285200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  In situ scanning probe microscopy studies of tetanus toxin-membrane interactions.

Authors:  Andrea L Slade; Joseph S Schoeniger; Darryl Y Sasaki; Christopher M Yip
Journal:  Biophys J       Date:  2006-09-22       Impact factor: 4.033

2.  Mini-beam collimator enables microcrystallography experiments on standard beamlines.

Authors:  Robert F Fischetti; Shenglan Xu; Derek W Yoder; Michael Becker; Venugopalan Nagarajan; Ruslan Sanishvili; Mark C Hilgart; Sergey Stepanov; Oleg Makarov; Janet L Smith
Journal:  J Synchrotron Radiat       Date:  2009-01-10       Impact factor: 2.616

3.  Comparative in vitro and in vivo assessment of toxin neutralization by anti-tetanus toxin monoclonal antibodies.

Authors:  Mehdi Yousefi; Roya Khosravi-Eghbal; Ahmad Reza Mahmoudi; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Fazel Shokri
Journal:  Hum Vaccin Immunother       Date:  2013-10-14       Impact factor: 3.452

4.  A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicity.

Authors:  Rui Yu; Shaoqiong Yi; Changming Yu; Ting Fang; Shuling Liu; Ting Yu; Xiaohong Song; Ling Fu; Lihua Hou; Wei Chen
Journal:  Clin Vaccine Immunol       Date:  2011-08-03

Review 5.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

6.  Biophysical comparison of diphtheria and tetanus toxins with the formaldehyde-detoxified toxoids, the main components of diphtheria and tetanus vaccines.

Authors:  Husam Alsarraf; Emil Dedic; Morten J Bjerrum; Ole Østergaard; Max Per Kristensen; Jesper W Petersen; René Jørgensen
Journal:  Virulence       Date:  2017-05-16       Impact factor: 5.882

7.  Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.

Authors:  A Nowakowski; C Wang; D B Powers; P Amersdorfer; T J Smith; V A Montgomery; R Sheridan; R Blake; L A Smith; J D Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

8.  Gangliosides as high affinity receptors for tetanus neurotoxin.

Authors:  Chen Chen; Zhuji Fu; Jung-Ja P Kim; Joseph T Barbieri; Michael R Baldwin
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

9.  Clostridium perfringens alpha-toxin recognizes the GM1a-TrkA complex.

Authors:  Masataka Oda; Michiko Kabura; Teruhisa Takagishi; Ayaka Suzue; Kaori Tominaga; Shiori Urano; Masahiro Nagahama; Keiko Kobayashi; Keiko Furukawa; Koichi Furukawa; Jun Sakurai
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

10.  Characterisation of a panel of anti-tetanus toxin single-chain Fvs reveals cooperative binding.

Authors:  Nathan Scott; Omar Qazi; Michael J Wright; Neil F Fairweather; Mahendra P Deonarain
Journal:  Mol Immunol       Date:  2010-04-22       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.